U.S. FDA nod for 20/20 BioResponse’s CoronaCheck ™ rapid test kit

The testing kits will be available with public health providers, hospitals and other medical institutions based in the U.S. CoronaCheck ™ was tested on 760 clinical samples in China BioResponse- a subsidiary of 20/20 GeneSystems....

Oxford scientists create rapid testing technology for COVID-19

Scientists from Oxford University have reportedly created a technology to accelerate the testing for COVID-19. The test is validated at China’s Shenzen Luohou People’s Hospital with real clinical samples. It is claimed to be fas....

Air Co. plans hand sanitizer bottle donation to local restaurants

Air Co., a technology and lifestyle company, has reportedly redirected 100% production capacity of its CO2-based vodka to the development of hand sanitizer. The recent shift in the development of a new product line has been carried out, in ....

Sanofi, Regeneron reveal plans to test Kevzara on COVID-19 patients

While the coronavirus manages to spread across major global economics, scientists and researchers all over the world are plowing their way to find a definite cure for this current pandemic. Recently, New York-based biotech firm Regeneron P....

Verizon allocates $10 million for providing COVID-19 relief services

Verizon has announced to support communities by contributing $10 million to provide relief services for people impacted by the ongoing coronavirus (COVID-19) pandemic. The company has tripled its monthly data allowance for its Verizon ....

Virometix’s first-in-human trial of RSV receives approval from FAMHP

Respiratory syncytial virus (RSV) is a seasonal virus infection that can cause severe lower respiratory infection   The vaccine candidate can induce antibodies capable of neutralizing the virus Virometix, a private Swiss biotech ....

Spero Therapeutics receives ODD for its oral drug SPR720 from the FDA

Spero Therapeutics, Inc., a renowned Massachusetts-based clinical-stage, multi-asset biopharmaceutical company, has reportedly announced that the United States Food and Drug Administration has granted its oral drug SPR720 the orphan drug de....

Innate Pharma doses first patient in IPH5201 Phase 1 clinical trial

The IPH5201 Phase I clinical trial is backed by positive pre-clinical results shown at the SITC AstraZeneca, the company’s partner, is the sponsor of the clinical study in solid tumors A commercial stage oncology-focused biotech ....

CytoDyn files IND with FDA for PRO 140 trial in coronavirus treatment

Leronlimab can reduce the mortality rate in patients with moderate to severe cases of coronavirus   Patients will be treated with leronlimab drug over a period of 4 weeks plus allowed windows CytoDyn Inc. – a Vancouver base....

Royalty Pharma acquires MGH’s royalty interest in Entyvio for $94 Mn

Royalty Pharma, one of the leading companies engaged in acquiring pharmaceutical royalties, has reportedly acquired royalties on Entyvio®(vedolizumab) from Massachusetts General Hospital (MGH) for USD 94 million. For the record, Entyvi....

Our Contributors

$row3->name
Mateen Dalal
$row3->name
Akshay Kedari
« First6364656667Last »